Navigation Links
Arthritis Foundation and Takeda Launch First-Ever National Gout Public Service Announcement (PSA) Campaign, Urging People Living With Gout to 'Keep Enjoying Life's Simple Pleasures'
Date:9/13/2010

cutting-edge research in search of a cure for arthritis.
  • Public Health: The Arthritis Foundation aims to increase public awareness of arthritis as the most common cause of disability, to prevent arthritis whenever possible, and to promote early diagnosis and access to the resources people with arthritis need to cope with their disease.
  • Public Policy: The Arthritis Foundation works at both the national and local levels to advance legislative policy issues on behalf of the 46 million adults and approximately 300,000 children in America with doctor-diagnosed arthritis.

  • The Arthritis Foundation offers resources to people who live with gout and other forms of arthritis through many communications vehicles, such as the magazine Arthritis Today; through local offices across the country that offer resources and programs for people with arthritis; and through its website, www.arthritis.org.

    About Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc.

    Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology and gastroenterology treatments, and seek to bring innovative products to patients through a pipeline that includes compounds in development for diabetes, cardiovascular disease, gastroenterology, neurology and other conditions. To learn more about these Takeda companies, visit www.tpna.com.


    '/>"/>
    SOURCE The Arthritis Foundation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
    2. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
    3. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
    4. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
    5. Evidence of Benefit Lacking for Many Common Ways of Treating Osteoarthritis of the Knee
    6. Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
    7. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
    8. Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis
    9. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
    10. Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
    11. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/4/2015)... 2015 Global and Chinese ... a professional and in-depth study on the current ... a focus on the Chinese market. Delivery of ... an order is placed. Complete report ... analyzing and profiling 8 major companies and supported ...
    (Date:9/4/2015)... 2015 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery ... the upcoming Rodman & Renshaw 17 th Annual ... New York City .  Dr. ... corporate overview on September 9, 2015. ...
    (Date:9/4/2015)... 04, 2015 Research ... addition of the "Veterinary Pharmaceutical Submissions in ... conference to their offering. This ... of the constituent parts of the application for ... which a marketing authorisation is sought in the ...
    Breaking Medicine Technology:Surgical Gown Market 2020 Forecasts With a Focus on China 2Surgical Gown Market 2020 Forecasts With a Focus on China 3Surgical Gown Market 2020 Forecasts With a Focus on China 4Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3Veterinary Pharmaceutical Submissions in the EU: Two day Course - London, UK - December 7-8, 2015 2
    ... LA JOLLA, Calif., Dec. 12, 2011  Celladon Corp., a ... innovative treatments for cardiovascular diseases, announced today that its ... designation by the U.S. Food and Drug Administration (FDA) ... The Fast Track program of the FDA is designed ...
    ... GROVE, Pa., Dec. 12, 2011  Strategic Recovery Partnership (SRP) ... Builder™ , a subscription service that allows Third Party ... Health Plan Documents on demand. Replacing outdated software tools ... Doc Builder is available at fixed, affordable licensing ...
    Cached Medicine Technology:Celladon Corporation Receives FDA Fast Track Designation for Its Investigational Agent MYDICAR® for the Treatment of Heart Failure 2Celladon Corporation Receives FDA Fast Track Designation for Its Investigational Agent MYDICAR® for the Treatment of Heart Failure 3Celladon Corporation Receives FDA Fast Track Designation for Its Investigational Agent MYDICAR® for the Treatment of Heart Failure 4SRP Announces Plan Doc Builder for TPAs and Brokers of Healthcare Plans 2
    (Date:9/4/2015)... ... September 04, 2015 , ... ... company today announced that it has entered into a multi-year agreement with Health ... agreement to bridge the link between American healthcare, Jamaican healthcare and Health City ...
    (Date:9/3/2015)... ... 2015 , ... AlignLife of Wauwatosa is excited to hold its ... children and adults who don't have the ability to buy a jacket warm enough ... annual Coat Drive to help those in need." , This is AlignLife's third annual ...
    (Date:9/3/2015)... , ... September 03, 2015 , ... Allied Anesthesia is ... innovative medicine is the norm not the exception. , St. Jude was recently named ... Heart Association/American Stroke Association, making it one of only 10 hospitals in the state ...
    (Date:9/3/2015)... ... September 03, 2015 , ... ... privately held medical technology company that will bring low-cost cancer pre-screening tests to ... , Preora’s proprietary and automated technology platform detects and measures cellular changes at ...
    (Date:9/3/2015)... Portland, OR (PRWEB) , ... September 03, 2015 ... ... been named the academic partner for the Academy of Integrative Health & Medicine ... be under the direction of Tieraona Low Dog, MD, an internationally renowned educator, ...
    Breaking Medicine News(10 mins):Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 2Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 3Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 4Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 5Health News:EMED Agreement with Health City Cayman Islands Provides for Up to 80% Savings for Patients in Need of Medical Procedures 6Health News:AlignLife is Helping to Keep the Community Warm This Winter 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 3Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 2Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 3
    ... April 29 /Xinhua-PRNewswire-FirstCall/ -- Mindray,Medical International Limited (NYSE: ... of medical devices in China with a rapidly ... its financial,results for the first quarter ended March ... 7, 2008. Mindray,s management will hold an earnings,conference ...
    ... finds premiums have jumped 30%, while incomes have only ... -- Employer-based health insurance premiums have skyrocketed at a ... increases since 2000, a new study reveals. , According ... by the Robert Wood Johnson Foundation (RWJF), the average ...
    ... now be predicted more realistically according to a new ... Endocrinology & Metabolism (JCEM). The study revealed that anti-Mllerian ... menopause and are able to specify a womans reproductive ... levels of AMH in the blood reflect the number ...
    ... EPS of $0.28 Represents Increase of 47% Over Prior Year Period and ... ... Nash Corporation,(Nasdaq: KNSY ) today reported the results for its third ... Revenues: Sales and Royalties. Total revenues increased 9% to a record,level of ...
    ... Parental Alienation Awareness Day, MIAMI, April 29 ... Governor Bob Riley of Alabama,Governor Mike Beebe of ... of Mississippi, Governor Joe Manchin III of West ... proclamations declaring,April 25th as Parental Alienation Awareness Day., ...
    ... April 29 ev3 Inc. (Nasdaq:,EVVV) today announced that Robert ... the Bank of America 2008 Healthcare,Conference on Tuesday, May 13, ... CT). The Bank of America 2008 Healthcare Conference will be ... To access the webcast, go to the investors, section of ...
    Cached Medicine News:Health News:Mindray to Report First Quarter 2008 Financial Results on May 7, 2008 2Health News:Health Insurance Premiums Skyrocket 2Health News:Health Insurance Premiums Skyrocket 3Health News:Health Insurance Premiums Skyrocket 4Health News:Kensey Nash Reports Third Quarter Record Revenue and Sales 2Health News:Kensey Nash Reports Third Quarter Record Revenue and Sales 3Health News:Kensey Nash Reports Third Quarter Record Revenue and Sales 4Health News:Kensey Nash Reports Third Quarter Record Revenue and Sales 5Health News:Kensey Nash Reports Third Quarter Record Revenue and Sales 6Health News:Kensey Nash Reports Third Quarter Record Revenue and Sales 7Health News:Kensey Nash Reports Third Quarter Record Revenue and Sales 8Health News:Kensey Nash Reports Third Quarter Record Revenue and Sales 9Health News:Kensey Nash Reports Third Quarter Record Revenue and Sales 10Health News:Kensey Nash Reports Third Quarter Record Revenue and Sales 11Health News:Kensey Nash Reports Third Quarter Record Revenue and Sales 12Health News:Kensey Nash Reports Third Quarter Record Revenue and Sales 13Health News:Kensey Nash Reports Third Quarter Record Revenue and Sales 14Health News:Kensey Nash Reports Third Quarter Record Revenue and Sales 15Health News:Alabama, Arkansas, Georgia, Mississippi, West Virginia, and Maryland Declare April 25th Parental Alienation Awareness Day 2
    ... Whether for bypass grafting or creation of ... placed tissue tunnel is of the utmost ... is the answer for those seeking a ... configuration minimizes the risk of twisting or ...
    ... Cardiovascular Patch utilizes advanced fluoropolymer ... around penetrating suture and decrease ... much as 88 percent. This ... retention, multi-directional strength and low ...
    ... Stretch Vascular Grafts have met the ... procedures. Recognized for exceptional performance and ... of renowned surgeons worldwide. These grafts ... the spread of infection, and ensure ...
    ... Grafts have met the challenges of ... for exceptional performance and quality, they ... surgeons worldwide. These grafts require no ... of infection, and ensure utmost thrombectomy ...
    Medicine Products: